Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

INNV vs UNH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
INNV
InnovAge Holding Corp.

Medical - Care Facilities

HealthcareNASDAQ • US
Market Cap$1.10B
5Y Perf.-68.7%
UNH
UnitedHealth Group Incorporated

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$335.60B
5Y Perf.-0.6%

INNV vs UNH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
INNV logoINNV
UNH logoUNH
IndustryMedical - Care FacilitiesMedical - Healthcare Plans
Market Cap$1.10B$335.60B
Revenue (TTM)$946M$449.71B
Net Income (TTM)$-22M$12.04B
Gross Margin14.8%18.8%
Operating Margin1.5%4.2%
Forward P/E32.0x20.2x
Total Debt$101M$78.39B
Cash & Equiv.$64M$24.36B

INNV vs UNHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

INNV
UNH
StockMar 21May 26Return
InnovAge Holding Co… (INNV)10031.3-68.7%
UnitedHealth Group … (UNH)10099.4-0.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: INNV vs UNH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: UNH leads in 6 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. InnovAge Holding Corp. is the stronger pick specifically for recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
INNV
InnovAge Holding Corp.
The Defensive Pick

INNV is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 1.66, Low D/E 38.4%, current ratio 1.07x
  • +147.9% vs UNH's -3.2%
Best for: sleep-well-at-night
UNH
UnitedHealth Group Incorporated
The Insurance Pick

UNH carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 25 yrs, beta 0.59, yield 2.4%
  • Rev growth 11.8%, EPS growth -14.7%, 3Y rev CAGR 11.4%
  • 220.6% 10Y total return vs INNV's -66.6%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthUNH logoUNH11.8% revenue growth vs INNV's 11.8%
ValueUNH logoUNHLower P/E (20.2x vs 32.0x)
Quality / MarginsUNH logoUNH2.7% margin vs INNV's -2.3%
Stability / SafetyUNH logoUNHBeta 0.59 vs INNV's 1.66
DividendsUNH logoUNH2.4% yield; 25-year raise streak; the other pay no meaningful dividend
Momentum (1Y)INNV logoINNV+147.9% vs UNH's -3.2%
Efficiency (ROA)UNH logoUNH3.9% ROA vs INNV's -4.1%, ROIC 9.2% vs -6.8%

INNV vs UNH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

INNVInnovAge Holding Corp.
FY 2025
Other Operating Segment
100.0%$990,000
UNHUnitedHealth Group Incorporated
FY 2025
Unitedhealthcare
94.4%$332.4B
Optumhealth
5.6%$19.8B

INNV vs UNH — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLUNHLAGGINGINNV

Income & Cash Flow (Last 12 Months)

UNH leads this category, winning 5 of 6 comparable metrics.

UNH is the larger business by revenue, generating $449.7B annually — 475.4x INNV's $946M. UNH is the more profitable business, keeping 2.7% of every revenue dollar as net income compared to INNV's -2.3%. On growth, INNV holds the edge at +15.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricINNV logoINNVInnovAge Holding …UNH logoUNHUnitedHealth Grou…
RevenueTrailing 12 months$946M$449.7B
EBITDAEarnings before interest/tax$4M$23.2B
Net IncomeAfter-tax profit-$22M$12.0B
Free Cash FlowCash after capex$39M$19.7B
Gross MarginGross profit ÷ Revenue+14.8%+18.8%
Operating MarginEBIT ÷ Revenue+1.5%+4.2%
Net MarginNet income ÷ Revenue-2.3%+2.7%
FCF MarginFCF ÷ Revenue+4.1%+4.4%
Rev. Growth (YoY)Latest quarter vs prior year+15.5%+2.0%
EPS Growth (YoY)Latest quarter vs prior year-161.3%+0.7%
UNH leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

UNH leads this category, winning 4 of 5 comparable metrics.
MetricINNV logoINNVInnovAge Holding …UNH logoUNHUnitedHealth Grou…
Market CapShares × price$1.1B$335.6B
Enterprise ValueMkt cap + debt − cash$1.1B$389.6B
Trailing P/EPrice ÷ TTM EPS-36.73x27.95x
Forward P/EPrice ÷ next-FY EPS est.32.03x20.19x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple16.70x
Price / SalesMarket cap ÷ Revenue1.28x0.75x
Price / BookPrice ÷ Book value/share4.16x3.31x
Price / FCFMarket cap ÷ FCF41.22x20.88x
UNH leads this category, winning 4 of 5 comparable metrics.

Profitability & Efficiency

Evenly matched — INNV and UNH each lead in 4 of 8 comparable metrics.

UNH delivers a 11.5% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-8 for INNV. INNV carries lower financial leverage with a 0.38x debt-to-equity ratio, signaling a more conservative balance sheet compared to UNH's 0.77x.

MetricINNV logoINNVInnovAge Holding …UNH logoUNHUnitedHealth Grou…
ROE (TTM)Return on equity-8.2%+11.5%
ROA (TTM)Return on assets-4.1%+3.9%
ROICReturn on invested capital-6.8%+9.2%
ROCEReturn on capital employed-7.1%+9.7%
Piotroski ScoreFundamental quality 0–966
Debt / EquityFinancial leverage0.38x0.77x
Net DebtTotal debt minus cash$37M$54.0B
Cash & Equiv.Liquid assets$64M$24.4B
Total DebtShort + long-term debt$101M$78.4B
Interest CoverageEBIT ÷ Interest expense5.96x4.71x
Evenly matched — INNV and UNH each lead in 4 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

INNV leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in UNH five years ago would be worth $9,743 today (with dividends reinvested), compared to $3,150 for INNV. Over the past 12 months, INNV leads with a +147.9% total return vs UNH's -3.2%. The 3-year compound annual growth rate (CAGR) favors INNV at 7.6% vs UNH's -7.1% — a key indicator of consistent wealth creation.

MetricINNV logoINNVInnovAge Holding …UNH logoUNHUnitedHealth Grou…
YTD ReturnYear-to-date+55.7%+10.6%
1-Year ReturnPast 12 months+147.9%-3.2%
3-Year ReturnCumulative with dividends+24.5%-19.9%
5-Year ReturnCumulative with dividends-68.5%-2.6%
10-Year ReturnCumulative with dividends-66.6%+220.6%
CAGR (3Y)Annualised 3-year return+7.6%-7.1%
INNV leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

UNH leads this category, winning 2 of 2 comparable metrics.

UNH is the less volatile stock with a 0.59 beta — it tends to amplify market swings less than INNV's 1.66 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UNH currently trades 93.5% from its 52-week high vs INNV's 75.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricINNV logoINNVInnovAge Holding …UNH logoUNHUnitedHealth Grou…
Beta (5Y)Sensitivity to S&P 5001.66x0.59x
52-Week HighHighest price in past year$10.68$395.52
52-Week LowLowest price in past year$2.85$234.60
% of 52W HighCurrent price vs 52-week peak+75.7%+93.5%
RSI (14)Momentum oscillator 0–10050.275.9
Avg Volume (50D)Average daily shares traded291K7.9M
UNH leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

UNH leads this category, winning 1 of 1 comparable metric.

Wall Street rates INNV as "Hold" and UNH as "Buy". Consensus price targets imply 4.2% upside for UNH (target: $385) vs -15.8% for INNV (target: $7). UNH is the only dividend payer here at 2.35% yield — a key consideration for income-focused portfolios.

MetricINNV logoINNVInnovAge Holding …UNH logoUNHUnitedHealth Grou…
Analyst RatingConsensus buy/hold/sellHoldBuy
Price TargetConsensus 12-month target$6.80$385.43
# AnalystsCovering analysts852
Dividend YieldAnnual dividend ÷ price+2.4%
Dividend StreakConsecutive years of raises025
Dividend / ShareAnnual DPS$8.70
Buyback YieldShare repurchases ÷ mkt cap+0.7%+1.7%
UNH leads this category, winning 1 of 1 comparable metric.
Key Takeaway

UNH leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). INNV leads in 1 (Total Returns). 1 tied.

Best OverallUnitedHealth Group Incorpor… (UNH)Leads 4 of 6 categories
Loading custom metrics...

INNV vs UNH: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is INNV or UNH a better buy right now?

For growth investors, UnitedHealth Group Incorporated (UNH) is the stronger pick with 11.

8% revenue growth year-over-year, versus 11. 8% for InnovAge Holding Corp. (INNV). UnitedHealth Group Incorporated (UNH) offers the better valuation at 27. 9x trailing P/E (20. 2x forward), making it the more compelling value choice. Analysts rate UnitedHealth Group Incorporated (UNH) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — INNV or UNH?

On forward P/E, UnitedHealth Group Incorporated is actually cheaper at 20.

2x.

03

Which is the better long-term investment — INNV or UNH?

Over the past 5 years, UnitedHealth Group Incorporated (UNH) delivered a total return of -2.

6%, compared to -68. 5% for InnovAge Holding Corp. (INNV). Over 10 years, the gap is even starker: UNH returned +220. 6% versus INNV's -66. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — INNV or UNH?

By beta (market sensitivity over 5 years), UnitedHealth Group Incorporated (UNH) is the lower-risk stock at 0.

59β versus InnovAge Holding Corp. 's 1. 66β — meaning INNV is approximately 184% more volatile than UNH relative to the S&P 500. On balance sheet safety, InnovAge Holding Corp. (INNV) carries a lower debt/equity ratio of 38% versus 77% for UnitedHealth Group Incorporated — giving it more financial flexibility in a downturn.

05

Which is growing faster — INNV or UNH?

By revenue growth (latest reported year), UnitedHealth Group Incorporated (UNH) is pulling ahead at 11.

8% versus 11. 8% for InnovAge Holding Corp. (INNV). On earnings-per-share growth, the picture is similar: UnitedHealth Group Incorporated grew EPS -14. 7% year-over-year, compared to -37. 5% for InnovAge Holding Corp.. Over a 3-year CAGR, UNH leads at 11. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — INNV or UNH?

UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.

7% net margin versus -3. 6% for InnovAge Holding Corp. — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus -3. 5% for INNV. At the gross margin level — before operating expenses — INNV leads at 68. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is INNV or UNH more undervalued right now?

On forward earnings alone, UnitedHealth Group Incorporated (UNH) trades at 20.

2x forward P/E versus 32. 0x for InnovAge Holding Corp. — 11. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UNH: 4. 2% to $385. 43.

08

Which pays a better dividend — INNV or UNH?

In this comparison, UNH (2.

4% yield) pays a dividend. INNV does not pay a meaningful dividend and should not be held primarily for income.

09

Is INNV or UNH better for a retirement portfolio?

For long-horizon retirement investors, UnitedHealth Group Incorporated (UNH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

59), 2. 4% yield, +220. 6% 10Y return). InnovAge Holding Corp. (INNV) carries a higher beta of 1. 66 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (UNH: +220. 6%, INNV: -66. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between INNV and UNH?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

UNH pays a dividend while INNV does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

INNV

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 7%
Run This Screen
Stocks Like

UNH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Dividend Yield > 0.9%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform INNV and UNH on the metrics below

Revenue Growth>
%
(INNV: 15.5% · UNH: 2.0%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.